BRANFORD, Conn., May 24 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. , a medical device company focused on innovative non- invasive vital signs monitoring, announced today plans to present an overview of the Company at the Friedman, Billings, Ramsey & Co., Inc. Growth Conference, which is being held May 30 - 31, 2007 at the Grand Hyatt, New York, NY.
Andrew E. Kersey, CASMED(R)'s President and Chief Executive Officer, and Jeffery Baird, Chief Financial Officer, will provide a brief corporate overview, review the Company’s recent accomplishments and financial results, and discuss the Company’s recently introduced Cerebral Oximeter, FORE- SIGHT(TM). The FORE-SIGHT Cerebral Oximeter measures absolute cerebral tissue oxygen saturation and provides new information that allows clinicians to monitor and quickly respond to instances of brain tissue oxygen deprivation before damage to the brain occurs.
The presentation is scheduled to begin at 11:15 a.m. ET on Thursday, May 31 and will also be webcast live over the Internet. The webcast may be accessed via the Company’s website at www.casmed.com, and will be accessible until July 1, 2007. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast.
About CASMED(R)
Founded in 1984, CAS Medical Systems, Inc. is dedicated to the design and manufacture of innovative, non-invasive technologies and products vital to patient care in the most challenging clinical environments. Its current product lines include cerebral oximeters, blood pressure measurement technology, vital signs monitors, blood pressure cuffs, cardio-respiratory and apnea monitors and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CASMED products are used by clinicians worldwide.
For more information contact: ir@casmed.com Investors and Media FD John Capodanno 212-850-5705 jcapodanno@fd-us.com
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, and other risks detailed in the Company’s most recent Form 10-KSB and other Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms “anticipate,” “believe,” “estimate,” “expect,” “may,” “objective,” “plan,” “possible,” “potential,” “project,” “will” and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward- looking statements, whether as a result of future events, new information or otherwise.
CAS Medical Systems, Inc.
CONTACT: Investors and Media, John Capodanno of FD, +1-212-850-5705,jcapodanno@fd-us.com
Web site: http://www.casmed.com/
